-
PEAQX is a
competitive antagonist at the NMDA receptor.
Although originally described as 100-fold
selective for GluN1/GluN2A
receptors vs. GluN1/GluN2B...
- LY-235959 LY-274614 MDL-100453
Midafotel (d-CPPene) NPC-12626 NPC-17742 PBPD
PEAQX Perzinfotel PPDA SDZ-220581 Selfotel;
Glycine site antagonists: 4-Cl-KYN...
- LY-235959 LY-274614 MDL-100453
Midafotel (d-CPPene) NPC-12626 NPC-17742 PBPD
PEAQX Perzinfotel PPDA SDZ-220581 Selfotel;
Glycine site antagonists: 4-Cl-KYN...
- LY-235959 LY-274614 MDL-100453
Midafotel (d-CPPene) NPC-12626 NPC-17742 PBPD
PEAQX Perzinfotel PPDA SDZ-220581 Selfotel;
Glycine site antagonists: 4-Cl-KYN...
- LY-235959 LY-274614 MDL-100453
Midafotel (d-CPPene) NPC-12626 NPC-17742 PBPD
PEAQX Perzinfotel PPDA SDZ-220581 Selfotel;
Glycine site antagonists: 4-Cl-KYN...
- LY-235959 LY-274614 MDL-100453
Midafotel (d-CPPene) NPC-12626 NPC-17742 PBPD
PEAQX Perzinfotel PPDA SDZ-220581 Selfotel;
Glycine site antagonists: 4-Cl-KYN...
- LY-235959 LY-274614 MDL-100453
Midafotel (d-CPPene) NPC-12626 NPC-17742 PBPD
PEAQX Perzinfotel PPDA SDZ-220581 Selfotel;
Glycine site antagonists: 4-Cl-KYN...
- LY-235959 LY-274614 MDL-100453
Midafotel (d-CPPene) NPC-12626 NPC-17742 PBPD
PEAQX Perzinfotel PPDA SDZ-220581 Selfotel;
Glycine site antagonists: 4-Cl-KYN...
- LY-235959 LY-274614 MDL-100453
Midafotel (d-CPPene) NPC-12626 NPC-17742 PBPD
PEAQX Perzinfotel PPDA SDZ-220581 Selfotel;
Glycine site antagonists: 4-Cl-KYN...
- LY-235959 LY-274614 MDL-100453
Midafotel (d-CPPene) NPC-12626 NPC-17742 PBPD
PEAQX Perzinfotel PPDA SDZ-220581 Selfotel;
Glycine site antagonists: 4-Cl-KYN...